Sensus Healthcare Inc is a medical technology company that specializes in developing innovative solutions for the treatment of non-melanoma skin cancers and other dermatological conditions
The company focuses on providing non-invasive and effective therapies, particularly through its proprietary Sensus device that utilizes ultrasound technology for the precise targeting of cancerous tissues. In addition to skin cancer treatment, Sensus Healthcare also explores applications in other areas of oncology and dermatology, aiming to improve patient outcomes while minimizing side effects associated with traditional treatment methods. The company's commitment to research and development allows it to drive advancements in medical care, enhancing the quality of life for patients.
After the conclusion of the US market's regular session on Wednesday, let's examine the after-hours session and unveil the notable performers among the top gainers and losers.
Companies Reporting Before The Bell • Ares Management (NYSEARES) is expected to report quarterly earnings at $1.09 per share on revenue of $864.54 million.
Shares of 3M Company (NYSEMMM) fell sharply during Tuesday’s session after the company reported better-than-expected fourth-quarter EPS, but issued FY24 EPS guidance below estimates.
